Fluoxetine Treatment Induces EAAT2 Expression in Rat Brain

Overview

Journal J Neural Transm (Vienna)

Specialties Neurology
Physiology

Date 2010 Dec 17

PMID 21161710

Citations 9

Authors

M Zink

S Rapp

R Donev

P J Gebicke-Haerter

J Thome

Affiliations

Soon will be listed here.

Abstract

Synaptic pathology and disturbed glutamatergic neurotransmission contribute to the neurobiology of depression. Reduced expression of glutamate transporters, most importantly excitatory amino acid transporter (EAAT2), was reported in human studies and animal models. We therefore assessed the effects of antidepressant treatment upon EAAT2 expression. Male Sprague-Dawley rats received daily intraperitoneal injections of the antidepressants desipramine (DES, N = 7), fluoxetine (FLU, N = 7), tranylcypromine (TRAN, N = 5) or a saline control (CON, N = 5) for a period of 14 days. The expression of the major glial glutamate transporter EAAT2 was evaluated by semi-quantitative in situ hybridizations using a (35)S-labeled cRNA probe. Treatment with FLU significantly induced EAAT2 expression in hippocampal and cortical regions in comparison with saline injections, while DES and TRAN-applications did not exert significant effects. It can be postulated that increased expression of EAAT2 may counterbalance the tonus of glutamatergic neurotransmission. Our findings are in concert with human post-mortem findings, valid animal models of depression, antidepressive effects of NMDA-antagonists, and the glutamatergic theory of depression. Further studies should examine the effects of antidepressant treatments upon EAAT2 expression in rodent models of depression to further elucidate the underlying molecular mechanisms.

Citing Articles

Recurrent SLC1A2 variants cause epilepsy via a dominant negative mechanism.

Stergachis A, Pujol-Gimenez J, Gyimesi G, Fuster D, Albano G, Troxler M Ann Neurol. 2019; 85(6):921-926.

PMID: 30937933 PMC: 6800210. DOI: 10.1002/ana.25477.

Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders.

Parkin G, Udawela M, Gibbons A, Dean B World J Psychiatry. 2018; 8(2):51-63.

PMID: 29988908 PMC: 6033743. DOI: 10.5498/wjp.v8.i2.51.

Inter-individual differences in serotonin and glutamate co-transmission reflect differentiation in context-induced conditioned 50-kHz USVs response after morphine withdrawal.

Hamed A, Kursa M Brain Struct Funct. 2018; 223(7):3149-3167.

PMID: 29774428 PMC: 6132671. DOI: 10.1007/s00429-018-1683-4.

Involvement of glutamatergic neurotransmission in the antidepressant-like effect of zinc in the chronic unpredictable stress model of depression.

Manosso L, Moretti M, Colla A, Ribeiro C, Dal-Cim T, Tasca C J Neural Transm (Vienna). 2016; 123(3):339-52.

PMID: 26747027 DOI: 10.1007/s00702-015-1504-3.

Effects of ampicillin, cefazolin and cefoperazone treatments on GLT-1 expressions in the mesocorticolimbic system and ethanol intake in alcohol-preferring rats.

Rao P, Goodwani S, Bell R, Wei Y, Boddu S, Sari Y Neuroscience. 2015; 295:164-74.

PMID: 25813713 PMC: 4408259. DOI: 10.1016/j.neuroscience.2015.03.038.

References

Minelli A, Barbaresi P, Reimer R, EDWARDS R, Conti F . The glial glutamate transporter GLT-1 is localized both in the vicinity of and at distance from axon terminals in the rat cerebral cortex. Neuroscience. 2001; 108(1):51-9. DOI: 10.1016/s0306-4522(01)00375-x. View

Banasr M, Duman R . Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psychiatry. 2008; 64(10):863-70. PMC: 2709733. DOI: 10.1016/j.biopsych.2008.06.008. View

Torp R, Danbolt N, Babaie E, Bjoras M, Seeberg E, Storm-Mathisen J . Differential expression of two glial glutamate transporters in the rat brain: an in situ hybridization study. Eur J Neurosci. 1994; 6(6):936-42. DOI: 10.1111/j.1460-9568.1994.tb00587.x. View

Zink M, Vollmayr B, Gebicke-Haerter P, Henn F . Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression. Neuropharmacology. 2009; 58(2):465-73. DOI: 10.1016/j.neuropharm.2009.09.005. View

Yang Y, Gozen O, Watkins A, Lorenzini I, Lepore A, Gao Y . Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1. Neuron. 2009; 61(6):880-94. PMC: 2743171. DOI: 10.1016/j.neuron.2009.02.010. View

Figiel M, Maucher T, Rozyczka J, Bayatti N, Engele J . Regulation of glial glutamate transporter expression by growth factors. Exp Neurol. 2003; 183(1):124-35. DOI: 10.1016/s0014-4886(03)00134-1. View

Furuta A, Rothstein J, Martin L . Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J Neurosci. 1997; 17(21):8363-75. PMC: 6573756. View

Knackstedt L, Melendez R, Kalivas P . Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry. 2009; 67(1):81-4. PMC: 2795043. DOI: 10.1016/j.biopsych.2009.07.018. View

Shumake J, Conejo-Jimenez N, Gonzalez-Pardo H, Gonzalez-Lima F . Brain differences in newborn rats predisposed to helpless and depressive behavior. Brain Res. 2004; 1030(2):267-76. DOI: 10.1016/j.brainres.2004.10.015. View

10.

Wiedemann C . An intimate relationship. Nat Rev Neurosci. 2009; 10(5):318. DOI: 10.1038/nrn2643. View

11.

Zarate Jr C, Du J, Quiroz J, Gray N, Denicoff K, Singh J . Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system. Ann N Y Acad Sci. 2003; 1003:273-91. DOI: 10.1196/annals.1300.017. View

12.

Andin J, Stenfors C, Ross S, Marcusson J . Modulation of neuronal glutamate transporter rEAAC1 mRNA expression in rat brain by amitriptyline. Brain Res Mol Brain Res. 2004; 126(1):74-7. DOI: 10.1016/j.molbrainres.2004.03.023. View

13.

Paul I, Skolnick P . Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci. 2003; 1003:250-72. DOI: 10.1196/annals.1300.016. View

14.

Krystal J, Sanacora G, BLUMBERG H, Anand A, Charney D, Marek G . Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry. 2002; 7 Suppl 1:S71-80. DOI: 10.1038/sj.mp.4001021. View

15.

Sutherland M, Delaney T, Noebels J . Glutamate transporter mRNA expression in proliferative zones of the developing and adult murine CNS. J Neurosci. 1996; 16(7):2191-207. PMC: 6578530. View

16.

Mao Q, Yang T . Amitriptyline upregulates EAAT1 and EAAT2 in neuropathic pain rats. Brain Res Bull. 2009; 81(4-5):424-7. DOI: 10.1016/j.brainresbull.2009.09.006. View

17.

Takahashi K, Tsunoda M, Nishioka G, Kudo K, Ohata H, Kamijima K . Differential expression of VAMP2/synaptobrevin-2 after antidepressant and electroconvulsive treatment in rat frontal cortex. Pharmacogenomics J. 2003; 2(6):377-82. DOI: 10.1038/sj.tpj.6500135. View

18.

Willner P, Mitchell P . The validity of animal models of predisposition to depression. Behav Pharmacol. 2002; 13(3):169-88. DOI: 10.1097/00008877-200205000-00001. View

19.

Yang C, Huang C, Hsu K . Behavioral stress enhances hippocampal CA1 long-term depression through the blockade of the glutamate uptake. J Neurosci. 2005; 25(17):4288-93. PMC: 6725105. DOI: 10.1523/JNEUROSCI.0406-05.2005. View

20.

Moutsimilli L, Farley S, Dumas S, El Mestikawy S, Giros B, Tzavara E . Selective cortical VGLUT1 increase as a marker for antidepressant activity. Neuropharmacology. 2005; 49(6):890-900. DOI: 10.1016/j.neuropharm.2005.06.017. View